Beijing Great Wall Pharmaceutical Co., Ltd.

Introduction to Beijing Great Wall Pharmaceutical Factory. Beijing Great Wall Pharmaceutical Factory was established in 1980, originally under the General Logistics Department of the Chinese People's Liberation Army. At the end of 1998, according to the arrangement of the Central Military Commission, it was placed under the management of the State Economic and Trade Commission, with the superior supervisory unit being Beijing Rongli Industrial Corporation, a subsidiary of China Xinxing (Group) Corporation. It is a wholly state-owned enterprise. At present, it has total assets of 90 million yuan, with an annual output value of 50 million yuan and annual profits and taxes of 5 million yuan. It is a medium-sized second-class enterprise. In 1993, the National Bureau of Statistics announced that the factory had entered the "China's 500 Largest Pharmaceutical Industrial Enterprises" industry, ranking 208th. In 1997, Beijing Statistical Yearbook: it ranked 98th among large and medium-sized industrial enterprises by total profits and taxes; and 21st by contribution rate of total assets. The registered trademark is "Jingfeng". Hong Xuezhi, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference, and leaders of the four headquarters of the People's Liberation Army have visited the factory many times and wrote inscriptions to encourage "producing high-quality drugs to serve people's health" and "carrying forward our army's glorious traditions to build a healthy Great Wall for humanity". Enterprise scale: The factory covers an area of 50,000 square meters, divided into two production areas. The Wulidian production area is the base for traditional Chinese medicine raw materials and extraction, covering 28,000 square meters. The newly built traditional Chinese medicine extraction and warehouse building has a construction area of 5,000 square meters. The production area at No. 63, Xisihuan South Road, is the preparation base, covering 22,000 square meters. Two preparation buildings completed in 1990 have a construction area of 10,000 square meters, plus auxiliary facilities of 10,000 square meters. Beijing Great Wall Pharmaceutical Factory has strong technical strength, with 300 existing employees, of which technical personnel account for more than 20%. The factory environment is beautiful, and the workshops and equipment are advanced, meeting GMP standards. In Beijing, from 2001 to 2002, it invested 14 million yuan successively to update equipment, renovate workshops, and beautify the environment, enabling Great Wall Pharmaceutical Factory to fully meet modern production conditions. In 2002, it passed GMP certification. Products and services: Beijing Great Wall Pharmaceutical Factory has established a complete and systematic quality management documentation and rules, as well as a comprehensive quality assurance and quality inspection system, ensuring that the entire drug production process is carried out in accordance with GMP requirements and under controlled conditions. Beijing Great Wall Pharmaceutical Factory mainly produces tablets, lotions, granules, hard capsules, soft capsules, oral liquids, and deep-processed traditional Chinese medicines, with 7 dosage forms and more than 50 products. The "Jingfeng" brand drugs produced by the factory have won numerous awards. Weimeisu tablets won the 1986 Military High-Quality Product Award; Xiaojian oral liquid won the 1988 Military High-Quality Product Award, the 1990 National Medical and Health Science and Technology Achievement Exhibition Quality Award, and the 1990 First Traditional Chinese Medicine Culture Expo "Shennong Cup" Bronze Award; Xiaoer Qingfei Huatan Granules and Xiaoer Qingyan Granules won the 1989 Military High-Quality Product Award, and in 1992, in a social survey of Beijing residents, they were awarded the honorary title of "Most Welcomeable and Trustworthy Product by Capital Residents"; Duoxikang Soft Capsules and Xiaoer Qingyan Granules were selected as "Doctor-Recommended Drugs" in the 1993 "Doctor-Recommended Drug" activity. Enterprise purpose: The purpose of Beijing Great Wall Pharmaceutical Factory is to survive by quality, develop by variety, and benefit humanity; based in Beijing, facing the whole country, and going global. In the future, Beijing Great Wall Pharmaceutical Factory will pursue the development goals of high technology and high quality, continue to deepen reform, implement modern management systems, make positive efforts to ensure people's health, improve the level of drug use, and produce more and better high-quality and effective drugs. "Jingfeng" brand drugs offer you care, and Beijing Great Wall Pharmaceutical Factory builds a healthy Great Wall for everyone.